Earnings momentum and guidance shift at Exponent
Exponent (EXPO) has just paired higher third quarter and nine month earnings with raised full year 2026 revenue guidance, a combination that sharpened investor attention on the consulting specialist.
Recent price action suggests investors are responding to this mix of earnings and guidance. The share price has returned 20.36% over the past 30 days and 24.44% over 90 days. The 1 year total shareholder return of 21.21% contrasts with a 5 year total shareholder return that is down 28.04%, which points to momentum rebuilding after a weaker longer stretch.
Scan how Exponent's momentum compares with other consultancy and business service stocks by reviewing our curated 19 high quality undiscovered gems, which pair solid fundamentals with quieter share price histories.
After a near quarter jump in Exponent in just three months, the real issue is whether those stronger earnings and higher 2026 targets still leave meaningful upside on the table, or whether the big move has already been cashed in.
Most Popular Narrative: 7% Undervalued
Exponent's most followed valuation narrative pegs fair value at $90.67 a share, above the recent $84.02 close, so the narrative still frames the recent rally as only a partial catch up rather than a full rerating.
The capital light consulting model, with 2026 capex guided to only US$12 million to US$14 million and management expecting over US$100 million of free cash flow in the second half of 2026 after already returning US$272 million to shareholders over the prior 12 months, gives Exponent scope to continue dividends and buybacks while still funding growth initiatives. This can influence per share earnings and support net margin resilience.
See why 6 investors see Exponent as 7% undervalued.
Result: Fair Value of $90.67 (UNDERVALUED)
Still, the Exponent story can change quickly if margin pressure from higher operating costs returns, or if clients shift more work toward automated AI tools.
Find out about the key risks to this Exponent narrative.
Another view on Exponent’s valuation
On the cash flow side, the Simply Wall St DCF model points to a fair value of $138.67 for Exponent versus the recent $84.02 share price, which implies the stock trades at a 39.4% discount. That is a very different story compared with a modest premium on headline P/E. Which signal do you trust more when the gap is this wide?
Look into how the SWS DCF model arrives at its fair value.
Next Steps
Feeling optimistic but still unsure where you stand on Exponent after this mix of narratives and valuation signals? Act quickly and review the underlying positives for yourself by checking the 4 key rewards.
Looking for more investment ideas beyond Exponent?
Do not stop with one ticker. Fresh ideas often come from comparing a few different setups side by side, and the right tools make that much easier.
- Target dependable cash flows by scanning companies with strong payouts using our curated 7 dividend fortresses.
- Hunt for potential mispricing in quality businesses by working through the focused 38 high quality undervalued stocks.
- Prioritise resilience first by reviewing companies screened through the 31 resilient stocks with low risk scores.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com